Castration Resistant Prostatic Neoplasms Active Not Recruiting Phase 1 / 2 Trials for Cetrelimab (DB15421)

Back to Castration Resistant Prostatic Neoplasms

Also known as: Prostate Neoplasms, Castration-resistant / Castration-Resistant Prostatic Neoplasms / Prostatic Neoplasms, Castration-Resistant

IndicationStatusPhase
DBCOND0129140 (Castration Resistant Prostatic Neoplasms)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03431350A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate CancerTreatment